Ming-Chih Chang
- Epidemiology top 10%
- Hepatology top 2%
- Oncology
- Hematology
- Clinical Psychology
- Co-authors
- Hwei‐Fang TienIh‐Jen SuAnn‐Lii ChengPei‐Jer ChenChao A. HsiungWu‐Ching UenL.-T. ChenChih‐Hung Hsu
- Topics
- Acute Myeloid Leukemia Research (3 papers)T-cell and Retrovirus Studies (3 papers)Multiple Myeloma Research and Treatments (3 papers)
- Cited by
- HepatologyEpidemiologyOncology
- Partner nations
- TaiwanUnited StatesAustralia
In The Last Decade
Ming-Chih Chang
16 papers receiving 721 citations
Peers
Comparison fields: 5 of 80
- Epidemiology 445
- Hepatology 414
- Oncology 173
- Hematology 61
- Clinical Psychology 50
Countries citing papers authored by Ming-Chih Chang
This map shows the geographic impact of Ming-Chih Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Chih Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Chih Chang more than expected).
Fields of papers citing papers by Ming-Chih Chang
This network shows the impact of papers produced by Ming-Chih Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Chih Chang. The network helps show where Ming-Chih Chang may publish in the future.
Co-authorship network of co-authors of Ming-Chih Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Chih Chang. A scholar is included among the top collaborators of Ming-Chih Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Chih Chang. Ming-Chih Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 14 | |
| 4 | 5 | |
| 5 | 18 | |
| 6 | 130 | |
| 7 | 7 | |
| 8 | 29 | |
| 9 | Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial. | 8 |
| 10 | 3 | |
| 11 | 8 | |
| 12 | 24 | |
| 13 | 230 | |
| 14 | 11 | |
| 15 | 228 | |
| 16 | 6 |
About Ming-Chih Chang
Ming-Chih Chang is a scholar working on Hematology, Metals and Alloys and Transplantation, having authored 16 papers that have together received 728 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), T-cell and Retrovirus Studies (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hepatology (414 citations), Epidemiology (445 citations) and Oncology (173 citations). Ming-Chih Chang has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Hwei‐Fang Tien, Ih‐Jen Su, Ann‐Lii Cheng, Pei‐Jer Chen, Chao A. Hsiung, Wu‐Ching Uen, L.-T. Chen, Chih‐Hung Hsu, Jacqueline Whang‐Peng and Chao-Jung Tsao. Their work appears in journals such as PLoS ONE, Hepatology and Journal of Alloys and Compounds.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.